PAMED Physician Leaders Focus on Patient Test Result Law and Scope of Practice at August Meeting
Last Updated: Aug 15, 2019
Pennsylvania Medical Society (PAMED) physician leaders met in Harrisburg on Aug. 13-14, 2019, for a lively discussion of PAMED’s advocacy priorities and other issues affecting health care in the state.
Here’s a look at some of the issues PAMED’s Board of Trustees addressed at their latest meeting:
- Scope of practice – PAMED recently reported that Senate Bill 25, a bill that would allow CNRPs in Pennsylvania to practice without a collaborative agreement with a physician, passed the Pa. Senate on June 12. The bill has been referred to the House Professional Licensure Committee.
Recently, Rep. David Hickernell, who serves as Chair of the House Professional Licensure Committee, asked PAMED if we would be willing to meet with the PA Coalition of Nurse Practitioners (PCNP) to discuss the issue of CRNP independent practice. While PAMED strongly opposes legislation allowing CRNPs to practice without a collaborative agreement with a physician, we welcomed the opportunity to discuss our concerns directly with the nurses.
On Aug. 14, PAMED met with PCNP to discuss our position. We remain committed to supporting the physician as the leader of the health care team and opposing the expansion of the scope of practice for allied health care professionals. Learn more about PAMED’s scope of practice advocacy here.
- Amending the state’s Patient Test Result Information Act – The Patient Test Result Information Act (Act 112 of 2018), which was signed into law on Oct. 24, 2018, requires entities performing a diagnostic imaging service to directly notify the patient or patient’s designee when, in the judgment of the entity performing the test, a significant abnormality may exist.
The Board of Trustees approved a recommendation from PAMED’s Legislative Advocacy Task Force to advocate for amendments to Act 112. Using the term “significant abnormality” to trigger patient notification is problematic because a significant abnormality is difficult, if not impossible, to define and may ultimately cause confusion for patients. PAMED will pursue amendments to the law to take into consideration the need for clarity, clinical relevance, and what is in the best interest of patients.
Get details and FAQs on Act 112 here.
- The corporate practice of medicine – PAMED will create a task force to study the issue of the corporate practice of medicine in Pennsylvania. The goal of the task force will be to determine the current extent of the corporate ownership of physician practices statewide and how it impacts the practice of medicine and patient care.
- Recreational marijuana – The legalization of recreational marijuana continues to be discussed across the state and nation, and PAMED is being asked about our position. The topic will be addressed by the physician, resident, and medical student delegates at PAMED’s annual House of Delegates meeting in Hershey on October 25-27.
- Development of the PA Clinical Network – The Care Centered Collaborative at PAMED – our for-profit subsidiary – shared its third quarter update, which includes details on The Collaborative’s physician-led, clinically integrated network of Pennsylvania physician practices. Read the report.
Keep in mind that this is a brief overview of some of the many issues discussed during the Board of Trustees meeting. You can find a draft version of the pre-meeting agenda here. Meeting minutes from the current meeting will be posted online and made available to members after they are approved by the Board at its October meeting.
PAMED’s Board of Trustees will meet next on Oct. 25 during the House of Delegates held in Hershey, Pa. You can find out more about PAMED’s Board, including minutes from previous meetings, at www.pamedsoc.org/board. And, learn more about our upcoming House of Delegates on www.pamedsoc.org/HOD.